|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
108,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
5,721,727 |
Avg
Vol: |
2,596,545 |
52
Week Range: |
$73.89 - $73.89 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bradford Williamson Z III |
Officer |
|
2009-05-18 |
144 |
NP |
$0.00 |
$28,485 |
/ |
2,417 |
0 |
|
- |
|
Porter Steven Bryant |
Officer |
|
2009-05-18 |
144 |
NP |
$0.00 |
$28,473 |
/ |
2,416 |
0 |
|
- |
|
Welch Daniel G |
Officer |
|
2009-05-18 |
144 |
NP |
$0.00 |
$48,242 |
/ |
4,220 |
0 |
|
- |
|
Hodgman John |
SVP-Finance & CFO |
|
2009-05-15 |
4 |
D |
$11.68 |
$8,772 |
D/D |
(751) |
38,617 |
|
- |
|
Seiwert Scott |
VP, Rsearch/ Preclinical Dev. |
|
2009-05-15 |
4 |
D |
$11.68 |
$1,775 |
D/D |
(152) |
28,925 |
|
- |
|
Steele Robin Joan |
SVP, General Counsel |
|
2009-05-15 |
4 |
S |
$11.52 |
$11,036 |
D/D |
(958) |
53,403 |
|
- |
|
Armstrong Marianne |
Chief Med. Affairs/Reg. Off. |
|
2009-05-15 |
4 |
AS |
$11.52 |
$11,036 |
D/D |
(958) |
28,292 |
|
- |
|
Simon Howard Allan |
SVP-Human Resources |
|
2009-05-15 |
4 |
D |
$11.52 |
$4,182 |
D/D |
(363) |
29,037 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2009-05-15 |
4 |
D |
$11.52 |
$11,036 |
D/D |
(958) |
28,542 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2009-05-15 |
4 |
D |
$11.45 |
$19,328 |
D/D |
(1,688) |
206,897 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2009-05-15 |
4 |
AS |
$11.52 |
$11,036 |
D/D |
(958) |
28,290 |
|
- |
|
Steele Robin Joan |
SVP, General Counsel |
|
2009-05-13 |
4 |
S |
$11.96 |
$17,450 |
D/D |
(1,459) |
54,361 |
|
- |
|
Armstrong Marianne |
Chief Med. Affairs/Reg. Off. |
|
2009-05-13 |
4 |
AS |
$11.96 |
$17,438 |
D/D |
(1,458) |
29,250 |
|
- |
|
Simon Howard Allan |
SVP-Human Resources |
|
2009-05-13 |
4 |
D |
$11.96 |
$6,375 |
D/D |
(533) |
29,400 |
|
- |
|
Seiwert Scott |
VP, Rsearch/ Preclinical Dev. |
|
2009-05-13 |
4 |
D |
$11.42 |
$2,626 |
D/D |
(230) |
29,077 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2009-05-13 |
4 |
AS |
$11.96 |
$17,438 |
D/D |
(1,458) |
29,500 |
|
- |
|
Hodgman John |
SVP-Finance & CFO |
|
2009-05-13 |
4 |
D |
$11.42 |
$8,690 |
D/D |
(761) |
39,368 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2009-05-13 |
4 |
D |
$11.42 |
$28,915 |
D/D |
(2,532) |
208,585 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2009-05-13 |
4 |
AS |
$11.96 |
$17,450 |
D/D |
(1,459) |
29,248 |
|
- |
|
Seiwert Scott |
VP, Rsearch/ Preclinical Dev.O |
|
2009-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
114,498 |
|
- |
|
Seiwert Scott |
VP, Rsearch/ Preclinical Dev. |
|
2009-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
28,829 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2009-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
30,707 |
|
- |
|
Simon Howard Allan |
SVP-Human Resources |
|
2009-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
29,651 |
|
- |
|
Steele Robin Joan |
SVP, General Counsel |
|
2009-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
55,820 |
|
- |
|
Welch Daniel G |
CEO and President |
|
2009-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
110,000 |
211,117 |
|
- |
|
772 Records found
|
|
Page 18 of 31 |
|
|